ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Can-Fite BioPharma Ltd. Common Stock, par value $0.001 per share (CANF)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Can-Fite BioPharma Ltd. Common Stock, par value $0.001 per share
Symbol: CANF
Shares outstanding: 8,826,092 shares
Disclosed Ownership: 440,422 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:33:16 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	440,422	0	440,422	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	440,422	0	440,422	/s/ Steven Boyd	Steven Boyd